CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
San Antonio, Texas, United States and 30 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
San Antonio, Texas, United States and 210 other locations
Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mortality worldwide, with poor survival ...
Phase 2, Phase 3
San Antonio, Texas, United States and 27 other locations
A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...
Phase 1
San Antonio, Texas, United States and 22 other locations
for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung cancers are due to muta...
Phase 3
San Antonio, Texas, United States and 152 other locations
The main purpose of the study is to evaluate the safety of GDC-1971 in combination with either osimertinib or cetuximab. The study consists of a dose...
Phase 1
San Antonio, Texas, United States and 14 other locations
The primary objective of this study is to compare the efficacy of ABP 234 with the pembrolizumab reference product (Keytruda®).
Phase 3
San Antonio, Texas, United States and 31 other locations
deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab alone in participants with advanced or metastatic non-small cell lung...
Phase 3
San Antonio, Texas, United States and 233 other locations
This Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small ce ...
Phase 1, Phase 2
San Antonio, Texas, United States of America and 19 other locations
(Dato-DXd) in combination with pembrolizumab with or without platinum chemotherapy in participants with advanced or metastatic non-small cell lung...
Phase 1
San Antonio, Texas, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal